Curaleaf Holdings (CURLF) Inventory (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Inventory of $225.0 million for Q4 2025, up 3.73% year-on-year from $216.9 million in Q4 2024, and up 3.73% on a QoQ basis from $216.9 million in Q4 2024.
Curaleaf Holdings (CURLF) Inventory (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Inventory for 7 consecutive years, with $225.0 million the latest figure, recorded in Q4 2025.
- Quarterly Inventory rose 3.73% year-over-year to $225.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $225.0 million (up 3.73% YoY) and the FY2025 annual result came in at $225.0 million, up 3.73% from the prior year.
- Inventory rose to $225.0 million in Q4 2025 per CURLF's latest filing, from $216.9 million in the prior quarter.
- Over the last five years, Inventory for CURLF reached as high as $433.4 billion in Q1 2022 and fell as low as $215.9 million in Q4 2023.
- A 5-year average of $29.1 billion and a median of $237.3 million in 2021 frame the typical range for Inventory.
- Annual changes were most pronounced in 2022 — Inventory soared 182579.32% — and 2023, when it sank 49.83%.
- Year by year, Inventory stood at $248.1 million in 2021, then fell by 5.39% to $234.8 million in 2022, then fell by 8.04% to $215.9 million in 2023, then rose by 0.47% to $216.9 million in 2024, then climbed by 3.73% to $225.0 million in 2025.
- According to Business Quant data, Inventory over the past three periods registered $225.0 million, $216.9 million, and $227.2 million for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.36 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.55 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 8.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 178.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.49 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 64.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.72 Bn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 225.02 Mn |
| Dec 31, 2024 | 216.94 Mn |
| Sep 30, 2024 | 227.18 Mn |
| Jun 30, 2024 | 228.61 Mn |
| Dec 31, 2023 | 215.91 Mn |
| Sep 30, 2023 | 219.87 Mn |
| Jun 30, 2023 | 244.72 Mn |
| Dec 31, 2022 | 234.78 Mn |
| Sep 30, 2022 | 438.21 Mn |
| Jun 30, 2022 | 428.28 Mn |
| Mar 31, 2022 | 433.41 Bn |
| Dec 31, 2021 | 248.15 Mn |
| Sep 30, 2021 | 346.21 Mn |
| Jun 30, 2021 | 304.65 Mn |
| Mar 31, 2021 | 237.25 Mn |
| Dec 31, 2020 | 197.99 Mn |
| Sep 30, 2020 | 182.88 Mn |
| Dec 31, 2019 | 63.21 Mn |